On Monday, Lucid Diagnostics Inc (NASDAQ: LUCD) was 21.50% up from the session before settling in for the closing price of $1.07. A 52-week range for LUCD has been $0.63 – $1.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 129.86% over the past five years. When this article was written, the company’s average yearly earnings per share was at 84.60%. With a float of $24.38 million, this company’s outstanding shares have now reached $51.60 million.
Let’s look at the performance matrix of the company that is accounted for 70 employees. In terms of profitability, gross margin is -85.49%, operating margin of -1077.37%, and the pretax margin is -1069.9%.
Lucid Diagnostics Inc (LUCD) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Lucid Diagnostics Inc stocks. The insider ownership of Lucid Diagnostics Inc is 58.92%, while institutional ownership is 5.02%.
Lucid Diagnostics Inc (LUCD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 84.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 58.74% during the next five years compared to -110.66% drop over the previous five years of trading.
Lucid Diagnostics Inc (NASDAQ: LUCD) Trading Performance Indicators
You can see what Lucid Diagnostics Inc (LUCD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of Lucid Diagnostics Inc (LUCD)
Lucid Diagnostics Inc (NASDAQ: LUCD) saw its 5-day average volume 1.08 million, a positive change from its year-to-date volume of 0.38 million. As of the previous 9 days, the stock’s Stochastic %D was 88.51%. Additionally, its Average True Range was 0.08.
During the past 100 days, Lucid Diagnostics Inc’s (LUCD) raw stochastic average was set at 74.03%, which indicates a significant increase from 70.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.43% in the past 14 days, which was higher than the 57.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8688, while its 200-day Moving Average is $0.8556. Nevertheless, the first resistance level for the watch stands at $1.5100 in the near term. At $1.7200, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9400. If the price goes on to break the first support level at $1.0800, it is likely to go to the next support level at $0.8600. Assuming the price breaks the second support level, the third support level stands at $0.6500.
Lucid Diagnostics Inc (NASDAQ: LUCD) Key Stats
There are 59,342K outstanding shares of the company, which has a market capitalization of 77.15 million. As of now, sales total 2,430 K while income totals -52,670 K. Its latest quarter income was 1,170 K while its last quarter net income were -12,370 K.
